• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

LuCE presents country reports based on 2023 research on financial toxicity

We are pleased to announce the launch of nine Lung Cancer Europe (LuCE) country reports based on the data from […]

Call To Action: Survey for 9th LuCE Report

Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]

Press Release: High risk of financial vulnerability after diagnosis: The majority of people impacted by lung cancer experience higher costs and reduction in income

Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis:  The majority of people impacted […]

8th Edition of the LuCE Report – Financial impact of lung cancer: A European perspective

This is an annual initiative led by lung cancer patient organisations, across Europe with the purpose of raising awareness relating […]

Disparities and challenges in Access to lung cancer diagnostics and treatment across Europe

This 2020 LuCE Position Paper covers data regarding access to lung cancer treatment and diagnosis, in order to raise awareness […]

Lung Cancer Europe (Luce) Position Paper 2015

Representing patient organizations from: Denmark, Germany, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom and Slovenia. The burden […]